The Valley Desk

NCT00237185 · Interventional trial

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Overall registry status Completed

Phase 2

Conditions Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov